Moses Holmium:YAG laser
DeviceHo:YAG with Moses pulse modulation
Other names: MOSES 2.0 Technology
NCT Number: NCT07516106
The purpose of this study is to compare two laser technologies that are routinely used during ureteroscopy for the treatment of kidney stones. Specifically, this study will compare a pulsed Thulium:YAG laser to a pulse-modulated Holmium:YAG laser (Moses technology) to evaluate how effective and safe they are when used to break kidney stones.
Primary endpoints include stone-free rate and the zero stone-free rate at a standardized postoperative. Secondary endpoints include total operative time, lasing time (s), laser energy expended (J), efficiency (laser energy expended/stone volume; stone volume/lasing time). These endpoints aim to provide a comprehensive assessment of the clinical effectiveness and procedural efficiency of the two laser systems.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Mayo Clinic Arizona, Phoenix, Arizona, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ho:YAG with Moses pulse modulation
Other names: MOSES 2.0 Technology
p-Tm:YAG laser lithotripsy with long pulse mode
Other names: Thulio
Time frame: Month 1
Time frame: Month 1
Time frame: From first insertion of instruments to final removal of all instruments (up to 3 hours)
Time frame: From start of lasing to end of lasing (up to 1 hour)
Time frame: From start of lasing to end of lasing (up to 1 hour)
Time frame: From start of lasing to end of lasing (up to 1 hour)
Time frame: From start of lasing to end of lasing (up to 1 hour)
Contact information is provided by the study sponsor or research team.
Esteban Emiliani, MD, PhD
CONTACT
Rozalba Gogaj, MD, MPH
CONTACT
NYU Langone Health
Other
Prospective Multi-center Study Comparing Pulsed Tm:YAG Laser to Pulse Modulated Holmium Laser in the Treatment of Nephrolithiasis With Flexible And Navigable Ureteric Access Sheath (FANS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718802
Calculi, Female Urogenital Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07689565
Calculi, Female Urogenital Diseases
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT07636070
Calculi, Female Urogenital Diseases
Muş, Turkey (Türkiye)
View Trial DetailsNCT07615452
Calculi, Female Urogenital Diseases
View Trial Details